Northern Trust Corp Has $1.30 Million Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Northern Trust Corp lifted its stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 53.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,165 shares of the company's stock after purchasing an additional 9,865 shares during the period. Northern Trust Corp owned approximately 0.10% of Establishment Labs worth $1,298,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Quarry LP acquired a new stake in shares of Establishment Labs during the fourth quarter worth $27,000. R Squared Ltd acquired a new position in Establishment Labs during the fourth quarter valued at $36,000. KLP Kapitalforvaltning AS acquired a new position in Establishment Labs during the fourth quarter valued at $161,000. Hood River Capital Management LLC raised its position in Establishment Labs by 236.4% during the fourth quarter. Hood River Capital Management LLC now owns 5,920 shares of the company's stock valued at $273,000 after buying an additional 4,160 shares during the period. Finally, Handelsbanken Fonder AB raised its position in Establishment Labs by 32.3% during the fourth quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock valued at $378,000 after buying an additional 2,000 shares during the period. 72.91% of the stock is owned by institutional investors and hedge funds.

Establishment Labs Stock Down 0.1%

ESTA stock traded down $0.04 during mid-day trading on Friday, hitting $34.64. The stock had a trading volume of 445,316 shares, compared to its average volume of 476,482. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a 1-year low of $26.56 and a 1-year high of $58.00. The company has a fifty day moving average of $33.87 and a 200 day moving average of $37.58. The stock has a market capitalization of $1.00 billion, a price-to-earnings ratio of -13.43 and a beta of 0.73.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported ($0.70) earnings per share for the quarter, topping the consensus estimate of ($0.83) by $0.13. The company had revenue of $41.38 million for the quarter, compared to analyst estimates of $41.15 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The business's revenue was up 11.3% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.58) EPS. On average, equities analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Stephens reissued an "overweight" rating and set a $52.00 price target on shares of Establishment Labs in a research report on Thursday, March 6th. Needham & Company LLC raised Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 price target on the stock in a research report on Wednesday, May 14th. BTIG Research assumed coverage on Establishment Labs in a research report on Friday, May 16th. They set a "buy" rating and a $62.00 price target on the stock. Finally, Wall Street Zen lowered Establishment Labs from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $55.33.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.